Literature DB >> 10589074

Acid-base and electrolyte abnormalities in patients with acute leukemia.

H J Milionis1, C L Bourantas, K C Siamopoulos, M S Elisaf.   

Abstract

Disturbances of acid-base balance and electrolyte abnormalities are commonly seen in patients with acute leukemia. Our study aimed at illuminating the probable pathogenetic mechanisms responsible for these disturbances in patients with acute leukemia admitted to our hospital. We studied 66 patients (24 men and 44 women) aged between 17 and 87 years old on their admission and prior to any therapeutic intervention. Patients with diabetes mellitus, acute or chronic renal failure, hepatic failure, patients receiving drugs that influence acid-base status and electrolyte parameters during the last month, such as corticosteroids, cisplatin, diuretics, antacids, aminoglycosides, amphotericin, penicillin, and K(+), PO(4)(3-), or Mg(2+) supplements were excluded. Forty-one patients had at least one acid-base or electrolyte disturbance. There were no significant differences in the incidence of acid-base balance and electrolyte abnormalities between patients with acute myeloid leukemia (AML) and patients with acute lymphoblastic leukemia (ALL). The most frequent electrolyte abnormality was hypokalemia, observed in 41 patients (63%), namely in 34 patients with AML, and 7 with ALL; the main underlying pathophysiologic mechanism was inappropriate kaliuresis. Furthermore, hypokalemic patients more frequently experienced concurrent electrolyte disturbances (i.e., hyponatremia, hypocalcemia, hypophosphatemia, and hypomagnesemia), as well as various acid-base abnormalities compared to normokalemic patients. Hypokalemia in patients with acute leukemia may serve as an indicator of multiple concurrent, interrelated electrolyte disturbances, especially in patients with AML. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10589074     DOI: 10.1002/(sici)1096-8652(199912)62:4<201::aid-ajh1>3.0.co;2-1

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  9 in total

Review 1.  Drug-induced hypomagnesaemia : scope and management.

Authors:  Jacob Atsmon; Eran Dolev
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

2.  Phase I/II multicenter study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD4877 in patients with refractory acute myeloid leukemia.

Authors:  H M Kantarjian; S Padmanabhan; W Stock; M S Tallman; G A Curt; J Li; A Osmukhina; K Wu; D Huszar; G Borthukar; S Faderl; G Garcia-Manero; T Kadia; K Sankhala; O Odenike; J K Altman; M Minden
Journal:  Invest New Drugs       Date:  2011-04-15       Impact factor: 3.850

Review 3.  Kidney diseases associated with haematological cancers.

Authors:  Anirban Ganguli; Deirdre Sawinski; Jeffrey S Berns
Journal:  Nat Rev Nephrol       Date:  2015-06-02       Impact factor: 28.314

Review 4.  Bone resorption: supporting immunometabolism.

Authors:  Gustav van Niekerk; Megan Mitchell; Anna-Mart Engelbrecht
Journal:  Biol Lett       Date:  2018-02       Impact factor: 3.703

5.  Hypophosphatemia in the setting of metabolic bone disease: case reports and diagnostic algorithm.

Authors:  Alvin Lee Day; Sarah L Morgan; Kenneth G Saag
Journal:  Ther Adv Musculoskelet Dis       Date:  2018-06-15       Impact factor: 5.346

6.  Iatrogenic hyponatremia in hospitalized children: Can it be avoided?

Authors:  Peter Skippen; Robert Adderley; Mary Bennett; Arthur Cogswell; Norbert Froese; Mike Seear; David Wensley
Journal:  Paediatr Child Health       Date:  2008-07       Impact factor: 2.253

7.  Adrenal crisis in a patient with acute myeloid leukaemia.

Authors:  Wang Li; Ikemefuna Okwuwa; Karla Toledo-Frazzini; Alaaedin Alhomosh
Journal:  BMJ Case Rep       Date:  2013-07-09

8.  Acute Lymphoblastic Leukemia Presenting as Fanconi Syndrome.

Authors:  Tatsunori Yoshida; Hiroshi Tsujimoto; Takayuki Ichikawa; Shinji Kounami; Hiroyuki Suzuki
Journal:  Case Rep Oncol       Date:  2018-02-01

9.  Hypocalcemia in cancer patients: An exploratory study.

Authors:  José António Ferraz Gonçalves; Telma Costa; Joana Rema; Cristina Pinto; Miguel Magalhães; Ana Esperança; Luciana Sousa
Journal:  Porto Biomed J       Date:  2019-07-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.